about
Prevalence and Factors Associated with Multiple Provider Episodes in Texas: An Epidemiological Analysis of Prescription Drug Monitoring Program Data.Use of antipsychotics among elderly nursing home residents with dementia in the US: an analysis of National Survey Data.Prevalence and predictors of anticholinergic medication use in elderly nursing home residents with dementia: analysis of data from the 2004 National Nursing Home Survey.Antipsychotic use and expenditure in the United States.Prevalence, correlates, and associated outcomes of potentially inappropriate psychotropic use in the community-dwelling elderly.Comparative Cognitive Profile of Second-Generation Antidepressants in Elderly Nursing Home Residents With Depression.Polypharmacy trends in office visits by the elderly in the United States, 1990 and 2000.Healthcare outcomes associated with beers' criteria: a systematic review.Antipsychotic Use and Risk of Nursing Home Admission Among Dual-Eligible Medicare Beneficiaries: A Propensity-Matched Study.Comparative effectiveness of individual angiotensin receptor blockers on risk of mortality in patients with chronic heart failure.Which risk-adjustment index performs better in predicting 30-day mortality? A systematic review and meta-analysis.Atypical Antipsychotic Prescribing in Elderly Patients with Depression.Potentially inappropriate anticholinergic medication use in older adults with dementia.Risk of Mortality Associated with Anticholinergic Use in Elderly Nursing Home Residents with Depression.The Impact of Pharmacotherapy on Substance Use in Adolescents With Attention-Deficit/Hyperactivity Disorder: Variations Across Subtypes.The Prevalence of and Factors Associated With Receiving Concurrent Controlled Substance Prescriptions.Comparative risk of hip fractures in elderly nursing home patients with depression using paroxetine and other selective serotonin reuptake inhibitors.Risk of Dementia Among Elderly Nursing Home Patients Using Paroxetine and Other Selective Serotonin Reuptake Inhibitors.Risk of Mortality in Elderly Nursing Home Patients with Depression Using Paroxetine.Risk of Cognitive Decline Associated With Paroxetine Use in Elderly Nursing Home Patients With Depression.Antimuscarinic Medication Use in Elderly Patients with Overactive Bladder.Anticholinergic Medication Use and Risk of Fracture in Elderly Adults with Depression.Functional Status of Elderly Nursing Home Residents With Parkinson's Disease.Prevalence and predictors of non-evidence based proton pump inhibitor use among elderly nursing home residents in the US.Anticholinergic Medication Use and Risk of Dementia Among Elderly Nursing Home Residents with Depression.Comparative Effectiveness of Second-Generation Antidepressants in Reducing the Risk of Dementia in Elderly Nursing Home Residents with Depression.Determinants of atypical antipsychotic use among antipsychotic users in community-dwelling elderly, 1996-2004.Quality of life of patients with Parkinson's disease and neurodegenerative dementia: A nationally representative study.Cardiovascular Safety of Concomitant Use of Atypical Antipsychotics and Long-Acting Stimulants in Children and Adolescents With ADHD.Anticholinergic Medication Use and Risk of Pneumonia in Elderly Adults: A Nested Case-Control Study.Anticholinergic drugs and health-related quality of life in older adults with dementia.Potentially inappropriate anticholinergic medication use in community-dwelling older adults: a national cross-sectional study.Concurrent use of stimulants and second-generation antipsychotics among children with ADHD enrolled in Medicaid.Development and Validation of the RxDx-Dementia Risk Index to Predict Dementia in Patients with Type 2 Diabetes and Hypertension.Use of Statins and Risk of Dementia in Heart Failure: A Retrospective Cohort Study.Risk of manic switch associated with antidepressant therapy in pediatric bipolar depression.Health care consequences of black-box warnings for antidepressants in the United States and Canada.Concomitant antipsychotic prescribing in US outpatient settings.Datapoints: psychotropic drug use among elderly patients in home care in the United States.Risk of death in dual-eligible nursing home residents using typical or atypical antipsychotic agents.
P50
Q31136904-96B0B545-EBD8-4D42-964E-672B3B8F7E1BQ33480648-36BCFC51-B088-4760-87D0-EF6634220BFCQ33750631-604EE897-B6CC-4DEB-923E-3ED35D61D22FQ34589405-7A6A26EA-1BC7-4D09-B88D-EEA48E1D2846Q35957562-52072E47-7D9C-4142-B0CA-0F83CDD17532Q36551469-E17039EA-17B3-4B63-8A27-4B085C1CB99EQ36670163-3F943D78-32FC-44DD-AC8F-46CCCFA0BE72Q36740777-ECAE2D7E-60D5-4BBB-B98E-398A9D919B5FQ36942854-10B78A0F-AF1F-4B6F-895E-8616F2C28911Q37904934-D65F032D-6D92-422A-9EE2-08A977B3E549Q38346762-EA685150-71AF-4A4D-B88F-AF175D6EAE5CQ38615814-0BF7A12C-44A4-43C2-B48F-AAC4251C0F0BQ38616453-D3341FB4-164B-4028-BA92-9AF38585486CQ38705840-6ACDD532-5B12-486D-89C9-067DA1A6BE8DQ38742279-BA5D7F9A-E844-496C-B5D3-45EF6F58D3F7Q38756613-A84EEDE6-D45B-4BC7-B2F7-915F5801E000Q38840876-D7558AB2-F91A-4204-A50A-B14F7C3521BFQ38978599-1AECF006-29BD-4471-934D-E3BE04A02471Q39025277-3A0E192E-8E07-493F-8999-9B792D006756Q39264918-4B343FDE-F3AE-4ECA-BDF8-6B616AD2783FQ39342723-100A895B-AFE0-4CA9-B275-C5756EF894CAQ39688670-44E6D0B0-EEEA-4037-A9F2-C0CC96E3540AQ39712008-E261BB32-DEDD-446E-92FE-43B7460DBF2FQ39873543-4207CF93-3185-434A-A5F1-728031133902Q39921021-9EF8909D-D2F8-460C-96A6-291C5759CEF3Q40126173-F2A15338-BCAC-4232-B683-DAE89B7DA451Q40130174-5BC9FFBD-31F2-498E-9997-1ABFC0EA93B7Q40385636-4CF2CE0A-1918-4031-9744-ED3AE70D8887Q40400512-601BD028-6E2E-401A-9D41-60CA58F5CA7DQ40786255-27D26A9C-7CD8-4FA4-9473-8ADA60C1499EQ41018521-C5902EEB-5959-4CBD-9795-FCB6D90302A1Q41126664-E1DC799B-781E-4EDC-9892-C1FFBF870B92Q41131598-3896F231-523A-417E-87BD-6E6E58D2C3BAQ41165531-9B090BFD-DBE8-40DA-B53A-ADE43B4E7F09Q41368084-140A7033-9DF0-45A5-9BD1-336057348144Q41731877-D88F2109-3091-40F9-8443-2AB32D02CB4FQ43147990-D3030EE2-13E8-4956-85E1-E8A9AF856E99Q43280353-6B147617-6766-472A-8C37-591C1C3302B9Q43789835-A4DABAB7-9DB3-4018-9D64-B692670B9F92Q43795252-88C22E54-17D5-49B5-8CF9-F4151ADB2759
P50
description
researcher
@en
wetenschapper
@nl
name
R R Aparasu
@en
R R Aparasu
@nl
type
label
R R Aparasu
@en
R R Aparasu
@nl
prefLabel
R R Aparasu
@en
R R Aparasu
@nl
P106
P31
P496
0000-0003-2310-901X